Experimental and Molecular Medicine

Korean Society for Biochemistry and Molecular Biongy (생화학분자생물학회)
권호 표지

Receptor activator of NF-$\kappa$B ligand enhances the activity of macrophages as antigen presenting cells

Park, Hye-Won;Park, Ok-Jin;Shin, Ji-Eun;Choi, Young-Nim

  • Published : 2005.12.31
⟨ Previous Next ⟩

Abstract

Receptor activator of NFκB ligand (RANKL) is known as a key regulator of osteoclastogenesis. However, the fact that fibroblasts and periodontal ligament cells express RANKL in response to bacterial sub - stances, suggests that RANKL may have evolved as a part of the immunity to infection. As RANKL increases the survival and activity of dendritic cells, it may have similar effects on macrophages. To address this issue, we studied the effect of RANKL on various functions of macrophages using mouse bone marrow derived macrophages. RANKL en - hanced the survival of macrophages and up-regulated the expression of CD86. RANKL-treated macrophages showed increased allogeneic T cell activation and phagocytic activity compared to control cells. In addition, RANKL increased the expression of TNFα, MCP-1, and IL-6 but not of IL-10, IL-12, IFN-γ, and iNOS. Collectively, RANKL augmented the activity of macrophages especially as antigen presenting cells, suggesting its new role in immune regulation.

Keywords

References

  1. Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, Galibert L. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 1997;390:175-9 https://doi.org/10.1038/36593
  2. Arron JR, Vologodskaia M, Wong BR, Naramura M, Kim N, Gu H, Choi Y. A positive regulatory role for Cbl family proteins in tumor necrosis factor-related activation-induced cytokine (trance) and CD40L-mediated Akt activation. J Biol Chem 2001;276:30011-7 https://doi.org/10.1074/jbc.M100414200
  3. Bharti AC, Takada Y, Shishodia S, Aggarwal BB. Evidence that receptor activator of nuclear factor (NF)-kappaB ligand can suppress cell proliferation and induce apoptosis through activation of a NF-kappaB-independent and TRAF6-dependent mechanism. J Biol Chem 2004;279:6065-76 https://doi.org/10.1074/jbc.M308062200
  4. Belibasakis GN, Johansson A, Wang Y, Chen C, Kalfas S, Lerner UH. The cytolethal distending toxin induces receptor activator of NF-kappaB ligand expression in human gingival fibroblasts and periodontal ligament cells. Infect Immun 2005;73:342-51 https://doi.org/10.1128/IAI.73.1.342-351.2005
  5. Choi Y, Kim JJ. B cells activated in the presence of Th1 cytokines inhibit osteoclastogenesis. Exp Mol Med 2003; 35:385-92
  6. Fox SW, Chambers TJ. Interferon-gamma directly inhibits TRANCE-induced osteoclastogenesis. Biochem Biophys Res Commun 2000;276:868-72 https://doi.org/10.1006/bbrc.2000.3577
  7. Glowacki J, Jasty M, Goldring S. Comparison of multinucleated cells elicited in rats by particulate bone, polyethylene, or polymethylmethacrylate. J Bone Miner Res 1986;1:327-31
  8. Goldring SR, Roelke M, Glowacki J. Multinucleated cells elicited in response to implants of devitalized bone particles possess receptors for calcitonin. J Bone Miner Res 1988; 3:117-20
  9. Janeway Jr. CA, Travers P, Walport M, Shlomchik MJ. Immunobiology, 6th Ed, 2005, Garland Science, New York and London, USA and UK
  10. Josien R, Wong BR, Li HL, Steinman RM, Choi Y. TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. J Immunol 1999;162:2562-8
  11. Josien R, Li HL, Ingulli E, Sarma S, Wong BR, Vologodskaia M, Steinman RM, Choi Y. TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo. J Exp Med 2000;191: 495-502 https://doi.org/10.1084/jem.191.3.495
  12. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis, Nature 1999;397:315-23 https://doi.org/10.1038/16852
  13. Krukowski M, Kahn AJ. Inductive specificity of mineralized bone matrix in ectopic osteoclast differentiation. Calcif Tissue Int 1982;34:474-9 https://doi.org/10.1007/BF02411288
  14. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998; 93:165-76 https://doi.org/10.1016/S0092-8674(00)81569-X
  15. Lohmann-Matthes ML, Emmendoerffer A, Hao L. Influence of interleukin-2 on the differentiation of macrophages. Pathobiology 1991;59:117-21 https://doi.org/10.1159/000163627
  16. Lyons AB. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J Immunol Methods 2000;243:147-54 https://doi.org/10.1016/S0022-1759(00)00231-3
  17. Miyamoto T, Arai F, Ohneda O, Takagi K, Anderson DM, Suda T. An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor kappa B ligand. Blood 2000;96:4335-43
  18. Sakai H, Kobayashi Y, Sakai E, Shibata M, Kato Y. Cell adhesion is a prerequisite for osteoclast survival. Biochem Biophys Res Commun 2000;270:550-6 https://doi.org/10.1006/bbrc.2000.2485
  19. Sankar U, Patel K, Rosol TJ, Ostrowski MC. RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1. J Bone Miner Res 2004;19:1339-48 https://doi.org/10.1359/JBMR.040321
  20. Shin JH, Kukita A, Ohki K, Katsuki T, Kohashi O. In vitro differentiation of the murine macrophage cell line BDM-1 into osteoclast-like cells. Endocrinology 1995;136:4285-92 https://doi.org/10.1210/en.136.10.4285
  21. Shin MM, Kim YH, Kim SN, Kim GS, Baek JH. High extracellular $Ca^{2+}$ alone stimulates osteoclast formation but inhibits in the presence of other osteoclastogenic factors. Exp Mol Med 2003;35:167-74
  22. Tiranathanagul S, Yongchaitrakul T, Pattamapun K, Pavasant P. Actinobacillus actinomycetemcomitans lipopolysaccharide activates matrix metalloproteinase-2 and increases receptor activator of nuclear factor-kappaB ligand expression in human periodontal ligament cells. J Periodontol 2004;75: 1647-54 https://doi.org/10.1902/jop.2004.75.12.1647
  23. Tokalov SV, Henker Y, Schwab P, Metz P, Gutzeit HO. Toxicity and cell cycle effects of synthetic 8-prenylnaringenin and derivatives in human cells. Pharmacology 2004;71: 46-56 https://doi.org/10.1159/000076261
  24. Udagawa N, Takahashi N, Akatsu T, Tanaka H, Sasaki T, Nishihara T, Koga T, Martin TJ, Suda T. Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci USA 1990;87: 7260-4 https://doi.org/10.1073/pnas.87.18.7260
  25. Wong BR, Rho J, Arron J, Robinson E, Orlinick J, Chao M, Kalachikov S, Cayani E, Bartlett $3^{rd}$ FS, Frankel WN, Lee SY, Choi Y. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem 1997a;272:25190-4 https://doi.org/10.1074/jbc.272.40.25190
  26. Wong BR, Josien R, Lee SY, Sauter B, Li HL, Steinman RM, Choi Y. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell- specific survival factor. J Exp Med 1997b;186:2075-80 https://doi.org/10.1084/jem.186.12.2075
  27. Wong BR, Besser D, Kim N, Arron JR, Vologodskaia M, Hanafusa H, Choi Y. TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src, Mol. Cell 1999;4:1041-9
  28. Xing L, Venegas AM, Chen A, Garrett-Beal L, Boyce BF, Varmus HE, Schwartzberg PL. Genetic evidence for a role for Src family kinases in TNF family receptor signaling and cell survival. Genes Dev 2001;15:241-53 https://doi.org/10.1101/gad.840301
  29. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998;95:3597-602 https://doi.org/10.1073/pnas.95.7.3597
  30. Zhang X, Aubin JE, Kim TH, Payne U, Chiu B, Inman RD. Synovial fibroblasts infected with Salmonella enterica serovar Typhimurium mediate osteoclast differentiation and activation. Infect Immun 2004;72:7183-9 https://doi.org/10.1128/IAI.72.12.7183-7189.2004